parkinson Flashcards
Parkinsonism refers to the presence of…. (3)
rest tremors
rigidity
bradykinesia
how to treat Parkinson in early symptomatic stage without complications
physiotherapy and exercise regime
healthy and balanced diet
knowledge on disease
social support
classes of oral medications in antiparkinson
anticholinergic agents
MAO-B/COM-T inhibitors
dopamine agonists
levodopa
what are the 2 levodopa preparations
levodopa + benserazide: madopar
levodopa + carbidopa: sinemet
available as a regular form or long acting form
side effects of levodopa
short term: nausea, vomiting postural hypotension
long term: motor fluctuations and dyskinesia
What is an example of anticholinergics
trihexyphenidul (Artane) 2-15mg.day
advantages of anticholinergics
effective in controlling tremor
peripherally acting agents may be useful in treating sialorrhoea
SE of anticholinergics
dry mouth, sedation, constipation, urinary retention, delirium, confusion, hallucinations
how should anticholinergic agents be used
symptomatic mono therapy or as an adjunct to levodopa
example of MAO-B inhibitors (1)
selegiline
when is the MAO-B inhibitors used
mild antiparkinson activity
symptomatic monotherapy
how does MAO=B wrk
inhibit enzyme monoamine oxidase B, interferes with breakdown of dopamine
may delay the mitral brain cell degeneration
SE of MAO-B
heartburn, loss of appetite, nausea, constipation, dizziness, anxiety, headache, palpitation, insomnia, confusion, nightmares, visual hallucination
name 2 COMT inhibitors
entacopone
tolcapone
MOA of COMT
blocks an enzyme that converts levodopa into an inactive form
more levodopa available to enter the brain
only effective when used with levodopa
increases duration of each dose of levodopa, beneficial in treating ‘wearing off’ response
side effects of COMT
increased abnormal movements (dyskinesias) liver dysfunction (tolcapone) nausea, diarrhoea urinary discolouration visual hallucinations actions daytime drowsiness, sleep disturbances
name 5 dopamine agonists
bromocriptine, pergolide, piribedil, ropinirole, pramipexole
MOA of dopamine agonists
act directly on dopamine receptors in the brain to reduce the symptoms of PD
usage of dopamine agonists
prevent or delay onset of motor complications
SE of dopamine agonists
fibrosis, pedal edema, somnolence with ropinirole, pramipexole
arrhythmia
pergolide: restrictive valvular heart disease
When to use dopamine agonists
symptomatic mono therapy
adjunct to levodopa in the treatment of Parkinson’s disease
younger Parkinson’s disease patients, therapy should commence first with dopamine agonists rather than levodopa
what is amantadine
antiviral agents, accidentally discovered to have mild antiparkinsonian effect
given mono therapy or adjunct to levodopa
amantadine MOA
enhance release of stored dopamine
inhibit presynaptic uptake of catecholamine
dopamine receptor agonist
NMDA receptor antagonist (anti-glutamate)
antidyskinetic
when to use amantadine
reduce dyskinesia in patients with Parkinson’s disease who have motor fluctuations
SE of amantadine
limits its use in advanced disease
cognitive impairment (inability to concentrate), hallucination, insomnia, night ares, lived reticular
mottled reticulated discolouration of limbs